Early and late prognostic implications of coronary artery bypass timing after myocardial infarction

Dumbor L Ngaage1, Franco Sogliani, Augustine Tang

  • 1Lancashire Cardiac Centre, Blackpool Victoria Hospital, Blackpool, UK. dngaage@yahoo.com

Insights

Delaying coronary artery bypass grafting (CABG) after myocardial infarction (MI) reduces mortality. Optimizing patient condition and using left internal mammary artery grafts are crucial, irrespective of surgery timing.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Myocardial Infarction Management

Background:

  • The optimal timing for coronary artery bypass grafting (CABG) following myocardial infarction (MI) remains debated.
  • While early CABG post-MI may increase risks, its long-term survival impact is unclear.
  • Advances in perioperative care allow for earlier surgical intervention.

Purpose of the Study:

  • To investigate the association between the timing of CABG after MI and both operative outcomes and long-term survival.
  • To identify factors influencing mortality and morbidity in patients undergoing CABG at different intervals post-MI.

Main Methods:

  • Analysis of prospectively collected data from 8320 patients undergoing primary CABG between 1996 and 2010.
  • Patients were categorized into groups based on the interval between MI and CABG (0-30 days, 31-60 days, >90 days), and a control group with no MI.
  • Multivariate and Kaplan-Meier analyses were used to assess the effect of surgery timing on survival.

Main Results:

  • Hospital mortality and the frequency of urgent operations decreased significantly as the interval between MI and CABG increased.
  • Patients undergoing CABG within 90 days of MI exhibited higher rates of cardiac morbidity, co-morbidities, and postoperative organ dysfunction.
  • Ten-year survival improved with a longer MI-to-CABG interval, although the interval itself was not a multivariate risk factor for mortality.

Conclusions:

  • Mortality risk associated with CABG decreases with a longer interval from MI, likely due to improved patient condition and reduced surgical urgency.
  • Emphasis should be placed on preoperative optimization of organ systems and consistent use of left internal mammary artery grafts.
  • These factors are important for improving outcomes regardless of the proximity of CABG to the MI event.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...